Poland· PL-100068271
Trusopt
A dorzolamide product containing dorzolamidum, registered in Poland by Santen Oy. The same ATC class is registered in 19 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Dorzolamide is registered in 19 of 19 countries.
Countries holding a registration under ATC S01EC03 (dorzolamide), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 11 of them publish a price we can compare per daily dose
Dorzolamide · ATC S01EC03
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Dorzolamidum
- Manufacturer
- Santen Oy
- Country
- Poland (PL)
- ATC code
- S01EC03
- ATC class
- Dorzolamide
- Defined daily dose
- 0.3 ml, AT
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
1 priced- gtin05909990661312
- gtin05909990832262
- gtin059099906613291 but.po 5 mlPLN 21.46
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
4 interactions on record for dorzolamide.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dorzolamide · interactions on record
4 records
- 4 severe
Most severe, free to view
- Acetylsalicylic acidB01AC06severe
- Salicylic acidD01AE12severe
- Acetylsalicylic acidN02BA01severe
- Salicylic acidS01BC08severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dorzolamide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDORZOLAMID OLIKLAOlikla s.r.o., Kostelec nad Černými Lesy
- United StatesDorzolamide HClA-S Medication Solutions
- FinlandAikumSanoSwiss UAB
- BelgiumCosopt 20 mg/ml - 5 mg/mlSanten
- NetherlandsDorzolamide Aurobindo 20 mg/ml oogdruppels, oplossingAurobindo Pharma B.V.
- SwedenDimaz 20 mg/ml Ögondroppar, lösningZaklady Farmaceutyczne Polpharma SA
- FranceDORZOLAMIDE BGR 20 mg/ml, collyre en solutionBIOGARAN
- NorwayDorzolamid al compAliud Pharma
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Dorlazept, Dorzo-Vision
- Belgium · Trusopt, Trusopt 2 % Unit Dose
- Bulgaria · Дорзамед
- Cyprus · Dorolad, Dorzon
- Czechia · Dorzolamid Olikla, Dorzolamide Farmaprojects
- Germany · Dimaz, Dorlazept
- Denmark · Delazo, Dorzolamid Hexal
- Estonia · Dorzolamide Elvim, Trusopt
- Spain · Arzolan, Dimaz
- Finland · Itoco, Odyral
- France · Dorzolamide Arrow, Dorzolamide Bgr
- United Kingdom (Northern Ireland) · Dimaz, Dorzolamide
- Greece · Delazo, Dorolad
- Croatia · Dorvis, Dorzol
- Hungary · Dorzolep, Trusopt
- Ireland · Itoco, Trusopt
- Iceland · Dorzolamide Alvogen
- Italy · Dorzoclar, Dorzolamide Aurobindo
- Lithuania · Dorzolamide Actavis, Dorzolamide Elvim
- Luxembourg · Dorzo-Vision, Trusopt 2 % Unit Dose
- Latvia · Dorzolamide Actavis, Dorzolamide Elvim
- Netherlands · Dorzolamide Hydrochloride Aurobindo, Dorzolamide Viatris
- Norway · Dimaz, Trusopt
- Portugal · Dimaz, Dorcil
- Romania · Dorzolamidă Arena, Dorzopt
- Sweden · Dimaz, Dorzolamid Hexal
- Slovakia · Dorzolamid Olikla, Dozotens
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e2e3dfcf-d5a9-4e12-bba3-2d45fa0e23ed GET /v1/drugs/e2e3dfcf-d5a9-4e12-bba3-2d45fa0e23ed?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krople do oczu, roztwór",
"source": "urpl",
"strength": "20 mg/ml",
"packaging": "05909990661312 ¦ Rp ¦ Skasowane ¦ 10247\n1 fl. 5 ml\n05909990661329 ¦ Rp ¦ 13792\n1 butelka 5 ml\n05909990832262 ¦ Rp ¦ 63166\n3 butelki 5 ml",
"substance": "Dorzolamidi hydrochloridum 22.26 mg",
"common_name": "Dorzolamidum",
"pl_product_id": "100068271",
"pozwolenie_nr": "06613",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about dorzolamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.